$8.35
N/A
Últ. Act.: Sep 30, 7:28 PM
$8.35
N/A
OptimizeRx (OPRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
OptimizeRx (OPRX) publicó su última previsión de agosto 12, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $95M - $100M para el período.
En comparación con la previsión anterior, OptimizeRx mantenido redujo su previsión de ingresos desde un rango anterior de $95M - $100M.
OptimizeRx ha emitido 15 actualizaciones de orientación entre el noviembre 8, 2022 y el agosto 12, 2026. During this period, the company raised its outlook 8 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.09 | $-0.02 | $0.18 | $-0.01 |
| Actual | $0.16 | $0.14 | $0.51 | $0.20 |
| Surprise | +77.8% | +800.0% | +183.3% | +2100.0% |
| Revenue | ||||
| Estimate | $20.3M | $18.4M | $31.2M | $23.7M |
| Actual | $20.5M | $19.8M | $32.2M | $26.1M |
| Surprise | +1.21% | +8.01% | +3.39% | +10.1% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.15 | $0.40 | $0.09 | $0.12 |
| Revenue | ||||
| Consensus | $21.7M | $34.6M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $0.16 | $0.09 | 77.8 % |
| Q1 | May 12, 2026 | $0.14 | $-0.02 | 800.0 % |
| Q4 | Mar 5, 2026 | $0.51 | $0.18 | 183.3 % |
| Q3 | Nov 6, 2025 | $0.20 | $-0.01 | 2100.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $20.50M | $20.26M | 1.21 % |
| Q1 | May 12, 2026 | $19.84M | $18.37M | 8.01 % |
| Q4 | Mar 5, 2026 | $32.24M | $31.18M | 3.39 % |
| Q3 | Nov 6, 2025 | $26.07M | $23.67M | 10.1 % |